Floatz logo

CYCLOSPORIN A

Myelodysplastic Syndrome With Single Lineage Dysplasia

National Cancer Institute (NCI)protein_peptidePhase 2Dormant
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Myelodysplastic Syndrome With Single Lineage Dysplasia cohort.

Asset / SponsorPhaseRating
Fludarabine
Fred Hutchinson Cancer Center
Phase 3BB
Cyclophosphamide
Fred Hutchinson Cancer Center
Phase 3BB
FILGRASTIM
National Cancer Institute (NCI)
Phase 3BB
METHOTREXATE
National Cancer Institute (NCI)
Phase 3BB
DEXAMETHASONE
National Cancer Institute (NCI)
Phase 3BB

View all 28 →

Same molecule, other indications

CYCLOSPORIN A is also rated in:

non-Hodgkin lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
Chronic Phase Chronic Myelogenous LeukemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →